<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01879761</url>
  </required_header>
  <id_info>
    <org_study_id>13-0491</org_study_id>
    <nct_id>NCT01879761</nct_id>
  </id_info>
  <brief_title>Immune Resolution After Staphylococcus Aureus Bacteremia</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Chicago</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Chicago</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine how monocyte HLA-DR and other markers of immune&#xD;
      function change with time in patients with and without prior immune dysfunction who survive&#xD;
      sepsis from Staphylococcus aureus bacteremia.&#xD;
&#xD;
      We hypothesize that patients with prior immune dysfunction will have greater reductions in&#xD;
      HLA-DR and other markers of immune function after an episode of sepsis than people who do not&#xD;
      have prior immune dysfunction.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Anticipated">June 2022</completion_date>
  <primary_completion_date type="Anticipated">June 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>HLA-DR and cytokines</measure>
    <time_frame>0-30 days</time_frame>
    <description>Percent expression of HLA-DR on monocytes will be measured by flow cytometry. Cytokine levels will be measured by ELISA.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>New Infections</measure>
    <time_frame>0-90 days</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Mortality</measure>
    <time_frame>0-90 days</time_frame>
  </other_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">102</enrollment>
  <condition>Immune Response To Sepsis</condition>
  <condition>Staphylococcus Aureus Infection</condition>
  <arm_group>
    <arm_group_label>Immunosuppressed</arm_group_label>
    <description>Immunosuppressed includes patients with any one of the following:&#xD;
a diagnosis of a hematological malignancy&#xD;
a diagnosis of HIV&#xD;
myelosuppressive chemotherapy in the previous 90 days&#xD;
immune-modulating medications in the previous 90 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-Immunosuppressed</arm_group_label>
    <description>Subject does not fit immunosuppressed criteria</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Isolated monocytes from whole blood for HLA-DR measurement. Serum and plasma for cytokine&#xD;
      measurements&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Hospital inpatients with Staphylococcus aureus bacteremia who are over 18 years old.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  At least one blood culture positive for S. aureus&#xD;
&#xD;
          -  Patients aged ≥18 years&#xD;
&#xD;
          -  At least two of four systemic inflammatory response syndrome (SIRS) criteria on the&#xD;
             day of positive blood cultures. SIRS criteria are:&#xD;
&#xD;
               -  Body temperature less than 36°C(96.8°F) or greater than 38°C(100.4°F)&#xD;
&#xD;
               -  Heart rate greater than 90 beats per minute&#xD;
&#xD;
               -  Tachypnea (high respiratory rate), with greater than 20 breaths per minute; or,&#xD;
                  an arterial partial pressure of carbon dioxide less than 32 mmHg&#xD;
&#xD;
               -  WBC less than 4000 cells/mm³ (4 x 109 cells/L) or greater than 12,000 cells/mm³&#xD;
                  (12 x 109 cells/L); or the presence of greater than 10% immature neutrophils&#xD;
                  (band forms)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Sequential Organ Failure Assessment (SOFA) score &gt; 12 on day of positive blood&#xD;
             cultures&#xD;
&#xD;
          -  Survival expected to be &lt; 7 days from positive blood cultures&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Chicago Hospital</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>June 10, 2013</study_first_submitted>
  <study_first_submitted_qc>June 17, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 18, 2013</study_first_posted>
  <last_update_submitted>September 30, 2021</last_update_submitted>
  <last_update_submitted_qc>September 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Immunosuppressed</keyword>
  <keyword>Sepsis</keyword>
  <keyword>Staphylococcus Aureus</keyword>
  <keyword>Bacteremia</keyword>
  <keyword>HLA-DR</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Staphylococcal Infections</mesh_term>
    <mesh_term>Bacteremia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

